Antagonistic activity of spent culture supernatants of lactic acid bacteria against helicobacter pylori growth and infection in human gastric epithelial AGS cells

Journal of Food Science

Volumn 74, Issue 6, 2009, Pages

  Lin, Wen Hsin ^a   Lin, Chien Ku ^b   Sheu, Sen Je ^c   Hwang, Chin Fa ^b   Ye, Wan Ting ^b   Hwang, Wen Zhe ^c   Tsen, Hau Yang ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Bactericidal activity; Exclusion; Helicobacter pylori; LAB SCS; Lactic acid bacteria

Indexed keywords

ACETIC ACID; ANTIINFECTIVE AGENT; LACTIC ACID; UREASE;

ARTICLE; BACTERIAL COUNT; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM ADHERENCE; CELL LINE; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; ENTEROCOCCUS FAECIUM; ENZYMOLOGY; EPITHELIUM CELL; FECES; FOOD CONTROL; GROWTH, DEVELOPMENT AND AGING; HELICOBACTER PYLORI; HUMAN; INFANT; ISOLATION AND PURIFICATION; LACTOBACILLUS; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOGENICITY; PEDIOCOCCUS; PH; STOMACH MUCOSA; TIME;

ACETIC ACID; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL LINE; COLONY COUNT, MICROBIAL; CULTURE MEDIA, CONDITIONED; ENTEROCOCCUS FAECIUM; EPITHELIAL CELLS; FECES; FOOD MICROBIOLOGY; GASTRIC MUCOSA; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT; LACTIC ACID; LACTOBACILLUS; MICROBIAL VIABILITY; PEDIOCOCCUS; TIME FACTORS; UREASE;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 70350181782     PISSN: 00221147     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3841.2009.01194.x     Document Type: Article

References (41)

1. Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. 1998. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 93:2097-2101
2. Armuzzi A, Cremonini F, Ojetti V, Bartolozzi F, Canducci F, Candelli M, Santarelli L, Cammarota G, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A. 2001. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects duringHelicobacter pylori eradication therapy: a pilot study. Digestion 63:1-7.
3. Barrett E, Hayes M, O'connor P, Gardiner G, Fitzgerald GF, Stanton C, Ross RP, Hill C. 2007. Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius. Appl Environ Microbiol73:3719-3723
4. Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP. 1989. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J ClinMicrobiol 27:2328-2330
5. Canducci F, Cremonini F, Armuzzi A, Di Caro S, Gabrielli M, Santarelli L, Nista E, Lupascu A, DeMartini D, Gasbarrini A. 2002. Probiotics and Helicobacter pylori eradication. Dig Liver Dis 34:S81-3.
6. Coconnier MH, Lievin V, Hemery E, Servin AL. 1998. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilusstrain LB. Appl EnvironMicrobiol 64:4573-4580
7. Conlin VS, Curtis SB, Zhao Y, Moore ED, Smith VC, Meloche RM, Finlay BB, Buchan AM. 2004. Helicobacter pylori infection targets adherens junction regulatory proteins and results in increased rates of migration in human gastric epithelial cells. Infect Immun 72:5181-5192
8. Deraz SF, Karlsson EN, Khalil AA, Mattiasson B. 2007. Mode of action of acidocin D20079, a bacteriocin produced by the potential probiotic strain, Lactobacillus acidophilus DSM 20079. J IndMicrobiol Biotechnol 34:373-379 (Pubitemid 46599137)
9. Díaz-Muñiz I, Banavara DS, Budinich MF, Rankin SA, Dudley EG, Steele JL. 2006. Lactobacillus casei metabolic potential to utilize citrate as an energy source in ripening cheese: a bioinformatics approach. J ApplMicrobiol 101:872-882
10. Dunn BE, Cohen H, Blaser MJ. 1997. Helicobacter pylori. Clin Microbiol Rev 10: 720-741
11. Enroth H, Wreiber K, Rigo R, Risberg D, Uribe A, Engstrand L. 1999. In vitro aging of Helicobacter pylori: changes in morphology, intracellular composition and surface properties. Helicobacter 4:7-16.
12. Garrote GL, Abraham AG, De Antoni GL. 2000. Inhibitory power of kefir: the role of organic acids. J Food Prot 63:364-369
13. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. 2006.Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 6:699-709.
14. Gotteland M, Brunser O, Cruchet S. 2006. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther23:1077-1086
15. Hamilton-Miller JM. 2003. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents 22:360-366
16. Helander IM, vonWright A,Mattila-Sandholm TM. 1997. Potential of lactic acid bacteria and novel antimicrobials against Gram-negative bacteria. Trends Food Sci Technol 8:146-150.
17. John AM, Al-Mekhaizeem K, Neil L, Dhar R, Dhar PM, Al-Ali M, Al-Abkal HM, Haridas S. 2006. High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated froma multiracial population in Kuwait. Aliment Pharmacol Ther 24:1359-1366
18. Kang JH, Lee MS. 2005. In vitro inhibition of Helicobacter pylori by Enterococcus faecium GM-1. Can JMicrobiol 51:629-636
19. Koga T, Inoue H, Ishii C, Okazaki Y, Domon H, Utsui Y. 2002. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo. J Antimicrob Chemother 50:133-136
20. Kusters JG, Gerrits MM, Van Strijp JA, Vandenbroucke-Grauls CM. 1997. Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect Immun 65:3672-3679
21. Lesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL. 2007. Helicobacter pylori and probiotics. J Nutr 137:812S-8.
22. Lim JW, Kim H, Kim KH. 2003. Cell adhesion-related gene expression by Helicobacter pylori in gastric epithelial AGS cells. Int J Biochem Cell Biol 35:1284-1296
23. Lin WH, Hwang CF, Chen LW, Tsen HY. 2006. Viable counts, characteristic evaluation for commercial lactic acid bacteria products. FoodMicrobiol 23:74-81.
24. Lin WH, Yu B, Lin CK, Hwang WZ, Tsen HY. 2007. Immune effect of heat-killed multistrain of Lactobacillus acidophilus against Salmonella typhimurium invasion to mice. J ApplMicrobiol 102:22-31.
25. Malaty HM, Nyren O. 2003. Epidemiology of Helicobacter pylori infection. Helicobacter 8:8-12.
26. Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N. 1999. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 60:203-209
27. Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML. 1995. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 79:475-479
28. Millette M, Luquet FM, Lacroix M. 2007. In vitro growth control of selected pathogens by Lactobacillus acidophilus- andLactobacillus casei-fermented milk. Lett ApplMicrobiol 44:314-319
29. Nakamura H, Yoshiyama H, Takeuchi H, Mizote T, Okita K, Nakazawa T. 1998. Urease plays an important role in the chemotactic motility of Helicobacter pylori in a viscous environment. Infect Immun 66:4832-4837
30. Nam H, Ha M, Bae O, Lee Y. 2002. Effect of Weissella confusa strain PL9001 on the adherence and growth of Helicobacter pylori. Appl EnvironMicrobiol 68:4642-4645 (Pubitemid 34988151)
31. Oh Y, Osato MS, Han X, Bennett G, Hong WK. 2002. Folk yoghurt kills Helicobacter pylori. J ApplMicrobiol 93:1083-1088
32. Parvez S, Malik KA, Ah Kang S, Kim HY. 2006. Probiotics and their fermented food products are beneficial for health. J ApplMicrobiol 100:1171-1185
33. Perez-Perez GI, Rothenbacher D, Brenner H. 2004. Epidemiology of Helicobacter pylori infection. Helicobacter 9:1-6.
34. Presser KA, Ratkowsky DA, Ross T. 1997.Modelling the growth rate of Escherichia coli as a function of pH and lactic acid concentration. Appl nvironMicrobiol 63:2355-2360
35. Rokka S, Pihlanto A, Korhonen H, Joutsjoki V. 2006. In vitro growth inhibition of Helicobacter pylori by lactobacilli belonging to the Lactobacillus plantarum group. Lett ApplMicrobiol 43:508-513
36. Rolfe RD. 2000. The role of probiotic cultures in the control of gastrointestinal health.J Nutr 130:396S-402S.
37. SandersME. 2003. Probiotics: considerations for human health. Nutr Rev 61:91-99
38. SgourasD,Maragkoudakis P, Petraki K,Martinez-Gonzalez B, Eriotou E,Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A. 2004. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 70:518-526
39. Wang KY, Li SN, LiuCS, PerngDS, Su YC,WuDC, JanCM, Lai CH,Wang TN,WangWM. 2004. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. AmJ Clin Nutr 80:737-741
40. Witthuhn RC, Cilliers A, Britz TJ. 2005. Evaluation of different preservation techniques on the storage potential of Kefir grains. J Dairy Res 72:125-128
41. Zeppa G, Conterno L, Gerbi V. 2001. Determination of organic acids, sugars, diacetyl,and acetoin in cheese by high-performance liquid chromatography. J Agric Food Chem 49:2722-2726